Literature DB >> 15844595

[Investigation of p53 polymorphism for genetic predisposition of keloid and hypertrophic scar].

Chun-mei Wang1, Hyakusoku Hiko, Nando Nakazawa.   

Abstract

OBJECTIVE: To investigate the codon-72 polymorphism of the tumor suppressor gene p53, codon-72 encodes arginine (Arg) or proline (Pro) for a genetic predisposition,to keloid or hypertrophic scar.
METHODS: The distribution of codon 72 polymorphism of p53 gene was analyzed from the 54 keloid and 30 hypertrophic scar(HS)of the Japanese patients with restriction fragment length polymorphism analysis and DNA sequence analysis.
RESULTS: The frequency of the Proline-encoding alleles and Arginine-encoding alleles in the hypertrophic scar patients and the piercing-induced ear-lobe keloid patients, was deviated significantly from that in the normal Japanese controls.
CONCLUSIONS: The Proline-encoding allele and Arginine-encoding allele could have the risks for the hypertrophic scar and the piecing-induced ear-lobe keloid. Also, the pathogenesis of the hypertrophic scar seems to be different from that of keloid at the molecular level.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15844595

Source DB:  PubMed          Journal:  Zhonghua Zheng Xing Wai Ke Za Zhi        ISSN: 1009-4598


  3 in total

Review 1.  MicroRNA-21 in Skin Fibrosis: Potential for Diagnosis and Treatment.

Authors:  Yan Li; Juan Zhang; Yuying Lei; Lechun Lyu; Ruiling Zuo; Ting Chen
Journal:  Mol Diagn Ther       Date:  2017-12       Impact factor: 4.074

2.  Relationship between p53 gene codon-72 polymorphisms and hypertrophic scar formation following caesarean section.

Authors:  Jianhua Gao; Ying Chen; Nong Liao; Wei Zhao; Weisen Zeng; Yingtao Li; Shaojing Wang; Feng Lu
Journal:  Exp Ther Med       Date:  2014-03-05       Impact factor: 2.447

3.  Two Functional TP53 Genetic Variants and Predisposition to Keloid Scarring in Caucasians.

Authors:  Andrzej Dmytrzak; Agnieszka Boroń; Beata Łoniewska; Klaudyna Lewandowska; Iwona Gorący; Mariusz Kaczmarczyk; Andrzej Ciechanowicz
Journal:  Dermatol Res Pract       Date:  2019-11-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.